United Therapeutics (UTHR) Return on Capital Employed Growth (1y) (2011 - 2026)
United Therapeutics (UTHR) Return on Capital Employed Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.81 Bn | 32.07 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.47 Bn | 30.53 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.55 Bn | 23.49 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.10 Bn | 20.95 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.31 Bn | 18.50 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | 1,195.00 |
| 10 | Vireo Growth | 10.52 Bn | 10.37 Bn | 59.30 Mn | -679.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89.00 |
| Dec 31, 2025 | -2,560.00 |
| Sep 30, 2025 | -3,031.00 |
| Jun 30, 2025 | -203.00 |
| Mar 31, 2025 | -51.00 |
| Dec 31, 2024 | 2,792.00 |
| Sep 30, 2024 | 3,338.00 |
| Jun 30, 2024 | 416.00 |
| Mar 31, 2024 | 442.00 |
| Dec 31, 2023 | 125.00 |
| Sep 30, 2023 | -20.00 |
| Jun 30, 2023 | 36.00 |
| Mar 31, 2023 | -165.00 |
| Dec 31, 2022 | 602.00 |
| Sep 30, 2022 | 846.00 |
| Jun 30, 2022 | 733.00 |
| Mar 31, 2022 | 991.00 |
| Dec 31, 2021 | -260.00 |
| Sep 30, 2021 | -483.00 |
| Jun 30, 2021 | -431.00 |